| Q2 2024 |
47 |
$1.57B |
+$31M |
-$26.6M |
+$4.36M |
LQD, VCLT, IGLB, EMNT, VWOB
|
Restatement |
8/26/2024, 11:39 AM |
| Q1 2024 |
41 |
$1.59B |
+$36.4M |
-$69.4M |
-$33M |
LQD, VCLT, IGLB, EMNT, VWOB
|
13F-HR |
5/14/2024, 03:19 PM |
| Q4 2023 |
38 |
$1.64B |
+$19.9M |
-$136M |
-$116M |
LQD, VCLT, IGLB, SPIB, EMNT
|
13F-HR |
2/6/2024, 01:26 PM |
| Q3 2023 |
38 |
$1.62B |
+$19.3M |
-$8.34M |
+$10.9M |
LQD, VCLT, IGLB, IGIB, EMNT
|
13F-HR |
11/13/2023, 12:27 PM |
| Q2 2023 |
34 |
$1.7B |
+$20.7M |
-$107M |
-$86.7M |
LQD, VCLT, IGLB, IGIB, EMNT
|
13F-HR |
8/8/2023, 04:35 PM |
| Q1 2023 |
30 |
$1.81B |
+$668M |
-$5.46M |
+$662M |
LQD, VCLT, SPIB, IGLB, IGIB
|
13F-HR |
5/5/2023, 02:39 PM |
| Q4 2022 |
26 |
$1.1B |
+$22M |
-$24.2M |
-$2.24M |
LQD, VCLT, IGLB, SPIB, IGIB
|
13F-HR |
2/7/2023, 04:51 PM |
| Q3 2022 |
22 |
$1.07B |
+$30.2M |
-$17.2M |
+$13M |
LQD, VCLT, IGLB, IGIB, SPIB
|
13F-HR |
11/7/2022, 10:21 AM |
| Q2 2022 |
21 |
$1.13B |
+$23.1M |
-$21.1M |
+$1.99M |
LQD, VCLT, IGLB, SPIB, IGIB
|
13F-HR |
8/12/2022, 02:35 PM |
| Q1 2022 |
20 |
$1.25B |
+$243M |
-$16.6M |
+$226M |
LQD, VCLT, IGLB, SPIB, IGIB
|
13F-HR |
5/10/2022, 01:20 PM |
| Q4 2021 |
21 |
$1.12B |
+$15.1M |
-$386M |
-$371M |
LQD, VCLT, IGLB, SPIB, IGIB
|
13F-HR |
2/8/2022, 02:29 PM |
| Q3 2021 |
20 |
$1.49B |
+$24.7M |
-$437M |
-$412M |
LQD, VCLT, IGLB, SPIB, ANGL
|
13F-HR |
11/5/2021, 02:06 PM |
| Q2 2021 |
19 |
$1.92B |
+$18.2M |
-$217M |
-$198M |
LQD, VCLT, ANGL, IGLB, SPIB
|
13F-HR |
8/6/2021, 11:27 AM |
| Q1 2021 |
19 |
$2.05B |
$0 |
$0 |
|
LQD, VCLT, ANGL, IGLB, SPIB
|
13F-HR |
5/6/2021, 03:02 PM |